Search for Merck & Co Inc and
    1. December 17, 2014

      Juno Therapeutics vies for cancer treatment lead

      When Juno Therapeutics lists on Nasdaq on Friday, it will be one of the biggest events in a big year for the buoyant US...

    2. December 11, 2014

      Merck’s Ebola vaccine trial suspended

      The race to stem the spread of Ebola suffered a setback on Thursday when researchers suspended a clinical trial of a new...

    Special Reports

    1. Special Report: Doing Business in Lyon 2013

      Urban renewal is at the heart of ambitions to rise up the rankings in the economic pre...
    2. Sustainable Healthcare

      Better treatment, technology, data and innovation are changing the global life-saving ...
    Search more Special Reports on this topic.

    1. December 8, 2014

      Merck/Cubist: pony up

      In a year dominated by the rise and fall of the tax arbitrage deal, it is a relief to return to the classic model of pharma...

    2. December 8, 2014

      Superbug threat drives $9.5bn Merck deal

      The growing threat from deadly superbugs prompted Merck to spend about $9.5bn including debt to buy Cubist, the US biotech...

    3. December 7, 2014

      Merck’s Cubist takeover highlights lure of antibiotics

      The $9.5bn takeover of Cubist, the US biotech company, by Merck & Co highlights renewed interest from big pharma in the...

    4. November 26, 2014

      Ebola vaccine shows promise in trials

      Thousands of healthcare workers in west Africa could be given a vaccine against Ebola early next year after the first one to...

    5. October 27, 2014

      US energy retreats on bearish Goldman call

      Energy companies weighed on the broader market as Goldman Sachs trimmed its outlook for North American crude prices, sending...

    6. October 6, 2014

      Merck sale boosts Europe’s corporate bond market

      Europe’s struggling corporate bond market was given a boost on Monday when Merck, the US pharmaceutical group, launched a...

    7. July 29, 2014

      Pfizer refuses to rule out tax inversion deals

      Pfizer has called for “fundamental reform” of the US tax system – but said it was still interested in acquisitions that...

    8. June 29, 2014

      Green chemistry: Pharmaceutical companies try to clean up their act

      Pharmaceutical companies tend to highlight their role in saving lives, but say little about the impact their manufacturing...

    9. June 9, 2014

      Merck to buy Idenix in race for hepatitis C treatments

      Merck & Co has agreed to buy Idenix Pharmaceuticals for $3.85bn in a deal aimed at bolstering its position in the hotly...

    10. May 30, 2014

      Hopes for cancer cures offer comfort for battered pharma

      It is the Holy Grail of medical science. Ever since Hippocrates, the Greek physician, first described the disease more than...

    11. May 9, 2014

      Week in Review, May 10

      A round up of some of the week’s most significant corporate events and news stories. Paris keeps pressure on Alstom over...

    12. May 6, 2014

      Bayer / Merck: the right price?

      This looks expensive. Any deal done at 21 times historic earnings before interest, tax, depreciation and amortisation...

    13. May 6, 2014

      Bayer acquires Merck’s consumer healthcare business for $14.2bn

      Germany’s Bayer has agreed to buy Merck’s consumer healthcare business for $14.2bn, acquiring brands including Coppertone...

    14. April 29, 2014

      Sprint’s strength lifts telecoms sector

      Investor focus on the US telecoms sector ratcheted higher on Tuesday after strong results from the country’s third-largest...

    15. April 28, 2014

      Reckitt and Bayer circle Merck auction of consumer healthcare

      Merck of the US is in the final stages of selling its consumer healthcare unit for close to $14bn, with Reckitt Benckiser...

    16. April 13, 2014

      Drug groups step up race for hepatitis C treatments

      Drugmakers are stepping up the race for multibillion-dollar hepatitis C treatments after trial data showed how the disease...

    17. February 3, 2014

      Merck agrees €20m deal to tap into Ablynx’s immunotherapy talent

      A biotech company that uses antibodies from llamas and alpacas to fight disease has struck a deal with Merck to help the US...

    18. January 13, 2014

      Merck gets booster shot from clotting drug

      Gains in drugmaker Merck after preliminary approval for a blood clotting drug boosted its shares by more than 6 per cent,...

    19. December 26, 2013

      Merck tests ground for Iran partnership to produce medicines

      German pharmaceutical group Merck is seeking a partnership with an Iranian manufacturer to produce medicines in the country...

    20. December 5, 2013

      Merck agrees to buy AZ Electronic for £1.6bn

      German drugs and chemicals group Merck has moved to increase its presence in high-tech electronic devices by agreeing to...

    21. October 28, 2013

      Merck falls after miss on revenue

      Merck shares moved lower but the S&P500 touched another record high as company earnings were in focus. The health and...

    22. October 13, 2013

      Merck explores ‘risk-sharing’ deals

      Merck of Germany is in discussions with external investors to fund jointly some of its clinical trials, in an unusual...

    23. October 2, 2013

      Johnson & Johnson: never say never

      Johnson & Johnson will never break up. Its focus on continuity is acute. The current boss has been at the company for 25...

    24. October 1, 2013

      US defence stocks shake off shutdown

      US defence and aerospace contractors moved mostly higher to recover some recent losses as investors greeted the first day of...

    25. October 1, 2013

      Merck to cut 8,500 additional jobs

      Merck, the US drugmaker, is to cut a fifth of its workforce within two years as part of a plan to narrow the focus of its...

    26. September 23, 2013

      Bribery claims infect drug companies’ dealings in China

      It began as a rumour on a Chinese social media site in July, but the impact has swiftly spread around the world: allegations...

    27. September 22, 2013

      Pioneer medical fund takes in $94m

      A pioneering socially orientated private equity fund to finance medical products for the world’s poor has raised $94m from...

    28. August 13, 2013

      GSK subsidiary wins watchdog approval for HIV treatment

      GlaxoSmithKline stands to receive a substantial financial boost after US regulatory approval of a new HIV treatment produced...

    29. August 11, 2013

      Brazil faces brave new world of making hard decisions

      During the boom years, Brazil was often saved from taking hard decisions. Asian demand for commodities buoyed its external...

    30. August 8, 2013

      Surgery needed to keep Novartis in shape

      The strength of Novartis is that it does what a big drug company should do: it makes original drugs that cure or ease the...

    31. July 30, 2013

      Pharma gives US stocks a boost

      Pharmaceutical blue-chips Pfizer and Merck highlighted the mixed earnings season, as the S&P 500 continued its recent run of...

    32. July 28, 2013

      Ireland’s ‘patent cliff’ poses problems for exit of bailout

      The metal reactors at Pfizer’s 200-acre manufacturing plant in Ringaskiddy that make the drug Viagra are not as busy as they...

    33. July 5, 2013

      China’s watchdogs show they have teeth

      Tetra Pak became the latest multinational to be targeted by Chinese regulators on Friday, with the launch of an antitrust...

    34. July 4, 2013

      China drug audit gives pharmaceutical groups the chills

      After the gold rush of the past decade, the latest move this week by the Chinese authorities to probe the medicines sector...

    35. July 4, 2013

      China launches drug pricing probe

      China’s drug pricing authority has launched a wide-ranging probe into the costs of medicines at 60 domestic and...

    36. July 1, 2013

      Drugmakers: binding agents

      Big pharma and generic drugmakers are often at loggerheads. But they may need each other more than they care to admit. Aspen...

    37. June 28, 2013

      ‘Biosimilar’ drug ruling to hit Big Pharma

      European regulators have approved the first generic versions of a complex biological medicine, paving the way for...

    38. June 27, 2013

      Aspen Pharmacare agrees Merck plant acquisition

      Aspen Pharmacare has agreed to buy a manufacturing plant from Merck of the US as part of a $1bn deal, as the South African...

    Search for Merck & Co Inc and